Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02268175
Title Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Johns Hopkins University Baltimore Maryland 21231 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02115 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02115 United States Details
University of Washington Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field